Susac’s syndrome as an immune-related adverse event after pembrolizumab: a case report
- 31 Downloads
Immune checkpoint inhibitors are increasingly used in cancer treatment and have a significant impact on survival . Pembrolizumab is a recombinant monoclonal antibody that blocks the programmed death-1 (PD-1) receptor, which is an inhibitor of T-cell activation, and thereby can promote the immune response against the tumor . The increased immune response can also induce auto-immune side effects . For the first time, we report a case of Susac’s syndrome induced by pembrolizumab.
Compliance with ethical standards
Conflicts of interest
The authors declare that they have no competing interests.
The patient provided informed oral and written consent in accordance with specific national laws and the ethics standards laid down in the 1964 Declaration of Helsinki and its later amendments.
- 5.Kao JC, Liao B, Markovic SN, Klein CJ, Naddaf E, Staff NP, Liewluck T, Hammack JE, Sandroni P, Finnes H, Mauermann ML (2017) Neurological complications associated with anti-programmed death 1 (PD-1) antibodies. JAMA Neurol 74(10):1216–1222. https://doi.org/10.1001/jamaneurol.2017.1912 CrossRefPubMedPubMedCentralGoogle Scholar
- 7.Laubli H, Hench J, Stanczak M, Heijnen I, Papachristofilou A, Frank S, Zippelius A, Stenner-Liewen F (2017) Cerebral vasculitis mimicking intracranial metastatic progression of lung cancer during PD-1 blockade. J Immunother Cancer 5:46. https://doi.org/10.1186/s40425-017-0249-y CrossRefPubMedPubMedCentralGoogle Scholar
- 8.Weber JS, Hodi FS, Wolchok JD, Topalian SL, Schadendorf D, Larkin J, Sznol M, Long GV, Li H, Waxman IM, Jiang J, Robert C (2017) Safety profile of nivolumab monotherapy: a pooled analysis of patients with advanced melanoma. J Clin Oncol 35(7):785–792. https://doi.org/10.1200/jco.2015.66.1389 CrossRefPubMedGoogle Scholar
- 11.Kleffner I, Dorr J, Ringelstein M, Gross CC, Bockenfeld Y, Schwindt W, Sundermann B, Lohmann H, Wersching H, Promesberger J, von Konigsmarck N, Alex A, Guthoff R, Frijns CJ, Kappelle LJ, Jarius S, Wildemann B, Aktas O, Paul F, Wiendl H, Duning T (2016) Diagnostic criteria for Susac syndrome. J Neurol Neurosurg Psychiatry 87(12):1287–1295. https://doi.org/10.1136/jnnp-2016-314295 CrossRefPubMedGoogle Scholar